Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

Dowling, Ryan J.O., Zakikhani, Mahvash, Fantus, I. George, Pollak, Michael, Sonenberg, Nahum · 2007 · Cancer Research

Abstract

Metformin is used for the treatment of type 2 diabetes because of its ability to lower blood glucose. The effects of metformin are explained by the activation of AMP-activated protein kinase (AMPK), which regulates cellular energy metabolism. Recently, we showed that metformin inhibits the growth of breast cancer cells through the activation of AMPK. Here, we show that metformin inhibits translation initiation. In MCF-7 breast cancer cells, metformin treatment led to a 30% decrease in global protein synthesis. Metformin caused a dose-dependent specific decrease in cap-dependent translation, with a maximal inhibition of 40%. Polysome profile analysis showed an inhibition of translation initiation as metformin treatment of MCF-7 cells led to a shift of mRNAs from heavy to light polysomes and a concomitant increase in the amount of 80S ribosomes. The decrease in translation caused by metformin was associated with mammalian target of rapamycin (mTOR) inhibition, and a decrease in the phosphorylation of S6 kinase, ribosomal protein S6, and eIF4E-binding protein 1. The effects of metformin on translation were mediated by AMPK, as treatment of cells with the AMPK inhibitor compound C prevented the inhibition of translation. Furthermore, translation in MDA-MB-231 cells, which lack the AMPK kinase LKB1, and in tuberous sclerosis complex 2 null (TSC2−/−) mouse embryonic fibroblasts was unaffected by metformin, indicating that LKB1 and TSC2 are involved in the mechanism of action of metformin. These results show that metformin-mediated AMPK activation leads to inhibition of mTOR and a reduction in translation initiation, thus providing a possible mechanism of action of metformin in the inhibition of cancer cell growth. [Cancer Res 2007;67(22):10804–12]

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-07-2310

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Cited by

See all 1,001

Metadata

Authors
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N.
Affiliations
  • McGill University (CA)
  • Jewish General Hospital (CA)
  • Mount Sinai Hospital (CA)
  • 2Department of Oncology, McGill University;
Venue
Cancer Research
Published
2007-11-15
Volume
67
Issue
22
Pages
10804-10812
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2064656431
Cited by
933
References
52
Citations by year
2026: 16 · 2025: 22 · 2024: 30 · 2023: 30 · 2022: 37 · 2021: 49 · 2020: 59 · 2019: 49 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 67 · 2014: 70 · 2013: 60 · 2012: 74
FWCI
15.48
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship@McGill (McGill) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
metformin, mTOR, translation initiation, AMPK, breast cancer, cap-dependent translation, polysome profiling, ribosomal protein S6, eIF4E-binding protein 1, LKB1, TSC2, MCF-7 cells, MDA-MB-231 cells, tumor cell growth inhibition
MeSH terms
Animals, Breast Neoplasms, Humans, Metformin, Mice, Transgenic, Models, Biological, Multienzyme Complexes, Polyribosomes, Protein Kinases, Ribosomes, Protein Biosynthesis, Protein Serine-Threonine Kinases, Genes, Reporter, Cell Line, Tumor, Cell Proliferation, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-07-2310
The paper
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007). Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-07-2310

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.